Comprehensive analysis of immune, extracellular matrices and pathogens profile in lung granulomatosis of unexplained etiology

Carregando...
Imagem de Miniatura
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO-ELSEVIER INC
Citação
HUMAN PATHOLOGY, v.75, p.104-115, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
This study analyzed the type 1 and type 2 T helper (Th1/Th2) cytokines (including interleukins), immune cellular, matrix profile, and pathogens in granulomas with unexplained etiology compared to those with infectious and noninfectious etiology. Surgical lung biopsies from 108 patients were retrospectively reviewed. Histochemistry, immunohistochemistry, immunofluorescence, morphometry and polymerase chain reaction were used, respectively, to evaluate total collagen and elastin fibers, collagen I and III, immune cells, cytokines, matrix metalloproteinase-9, myofibroblasts, and multiple usual and unusual pathogens. No relevant polymerase chain reaction expression was found in unexplained granulomas. A significant difference was found between the absolute number of eosinophils, macrophages, and lymphocytes within granulomas compared to uninvolved lung tissue. Granulomas with unexplained etiology (UEG) presented increased number of eosinophils and high expression of interleukins (ILs) IL-4/IL-5 and transforming growth factor-beta. In sarcoidosis, CD4/CD8 cell number was significantly higher within and outside granulomas, respectively; the opposite was detected in hypersensitivity pneumonitis. Again, a significant difference was found between the high number of myofibroblasts and matrix metalloproteinase-9 in UEG, hypersensitivity pneumonitis, and sarcoidosis compared to granulomas of tuberculosis. Granulomas of paracoccidioisis exhibited increased type I collagen and elastic fibers. Th1 immune cellular profile was similar among granulomas with unexplained, infectious, and noninfectious etiology. In contrast, modulation of Th2 and matrix remodeling was associated with more fibroelastogenesis and scarring of lung tissue in UEG compared to infectious and noninfectious. We concluded that IL-4/IL-5 and transforming growth factor-beta might be used as surrogate markers of early fibrosis, reducing the need for genotyping, and promise therapeutic target in unexplained granulomas.
Palavras-chave
Granuloma, Immunohistochemistry, Immunofluorescence, PCR, Morphometry, Immune cells, Collagens
Referências
  1. Al Shammari B, 2015, J INFECT DIS, V212, P463, DOI 10.1093/infdis/jiv076
  2. Caillaud Denis M., 2012, Inflammation & Allergy Drug Targets, V11, P15
  3. Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3
  4. Fallowfield Jonathan A, 2006, Clin Liver Dis, V10, P481, DOI 10.1016/j.cld.2006.08.022
  5. Gentilini MV, 2011, IMMUNOBIOLOGY, V216, P1054, DOI 10.1016/j.imbio.2011.02.002
  6. Goldsby R, 2004, KUBY IMMUNOLOGY
  7. HEINZEL FP, 1995, CURR OPIN INFECT DIS, V8, P151, DOI 10.1097/00001432-199506000-00002
  8. Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009
  9. Johansson A, 2002, CANCER-AM CANCER SOC, V94, P1306, DOI 10.1002/cncr.10301
  10. Knudsen L, 2017, CELL TISSUE RES, V367, P607, DOI 10.1007/s00441-016-2543-2
  11. Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090
  12. Kunkel SL, 1996, SARCOIDOSIS VASC DIF, V13, P120
  13. Liang ZZ, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019329
  14. Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189
  15. Mukhopadhyay S, 2010, ARCH PATHOL LAB MED, V134, P667, DOI 10.1043/1543-2165-134.5.667
  16. Oda K, 2014, RESPIR INVESTIG, V52, P179, DOI 10.1016/j.resinv.2013.12.003
  17. Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007
  18. Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978
  19. Rosen Y, 2015, ARCH PATHOL LAB MED, V139, P252, DOI 10.5858/arpa.2014-0051-RA
  20. Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
  21. Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.55.091902.103810
  22. ULBRIGHT TM, 1980, AM J SURG PATHOL, V4, P13, DOI 10.1097/00000478-198004010-00002
  23. WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723